Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chul S Ha

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Phytotherapy Research : PTR|September 11, 2014
Tolerance of Phellodendron amurense bark extract (Nexrutine®) in patients with human prostate cancerGregory P Swanson, William E Jones, Chul S Ha, et al.
Cancer Journal (Sudbury, Mass.)|September 12, 2003
Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphomaBouthaina S Dabaja, Chul S Ha, Richard B Wilder, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
Clinical implications of incorporating heterogeneity corrections in mantle field irradiationSteven M Kirsner, Rajat J Kudchadker, Karl L Prado, et al.
Cancer Journal (Sudbury, Mass.)|March 6, 2004
Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21)Chul S Ha, Ming-Sheng Lee, Peter McLaughlin, et al.
Cancer|May 13, 2004
The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemiaKevin E Sanders, Chul S Ha, Jorge E Cortes-Franco, et al.
Cancer|September 20, 2013
Incidence of gastric involvement in patients with nongastrointestinal extranodal marginal zone lymphomaAli Mazloom, Alma Rodriguez, Chul S Ha, et al.
Cancer|February 22, 2002
Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphomaRichard B Wilder, Jorge E Romaguera, Susan L Tucker, et al.
The Journal of Biological Chemistry|January 7, 2014
A low-dose arsenic-induced p53 protein-mediated metabolic mechanism of radiotherapy protectionSuthakar Ganapathy, Shaowen Xiao, Mei Yang, et al.
Pediatric Neurosurgery|August 29, 2003
Pathologically proven cavernous angiomas of the brain following radiation therapy for pediatric brain tumorsJames E Baumgartner, Joann L Ater, Chul S Ha, et al.
Anticancer Research|December 25, 2009
Imexon augments sensitivity of human lymphoma cells to ionizing radiation: in vitro experimental studyHeunglae Cho, Masashi Koto, Oliver Riesterer, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Phytotherapy Research : PTR|September 11, 2014
Tolerance of Phellodendron amurense bark extract (Nexrutine®) in patients with human prostate cancerGregory P Swanson, William E Jones, Chul S Ha, et al.
Cancer Journal (Sudbury, Mass.)|September 12, 2003
Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphomaBouthaina S Dabaja, Chul S Ha, Richard B Wilder, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
Clinical implications of incorporating heterogeneity corrections in mantle field irradiationSteven M Kirsner, Rajat J Kudchadker, Karl L Prado, et al.
Cancer Journal (Sudbury, Mass.)|March 6, 2004
Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21)Chul S Ha, Ming-Sheng Lee, Peter McLaughlin, et al.
Cancer|May 13, 2004
The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemiaKevin E Sanders, Chul S Ha, Jorge E Cortes-Franco, et al.
Cancer|September 20, 2013
Incidence of gastric involvement in patients with nongastrointestinal extranodal marginal zone lymphomaAli Mazloom, Alma Rodriguez, Chul S Ha, et al.
Cancer|February 22, 2002
Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphomaRichard B Wilder, Jorge E Romaguera, Susan L Tucker, et al.
The Journal of Biological Chemistry|January 7, 2014
A low-dose arsenic-induced p53 protein-mediated metabolic mechanism of radiotherapy protectionSuthakar Ganapathy, Shaowen Xiao, Mei Yang, et al.
Pediatric Neurosurgery|August 29, 2003
Pathologically proven cavernous angiomas of the brain following radiation therapy for pediatric brain tumorsJames E Baumgartner, Joann L Ater, Chul S Ha, et al.
Anticancer Research|December 25, 2009
Imexon augments sensitivity of human lymphoma cells to ionizing radiation: in vitro experimental studyHeunglae Cho, Masashi Koto, Oliver Riesterer, et al.
Pageof 7